{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:31:01Z","timestamp":1783470661574,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.4158\/ep14339.ra","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T02:34:45Z","timestamp":1419388485000},"page":"190-199","source":"Crossref","is-referenced-by-count":27,"title":["Opioid Endocrinopathy"],"prefix":"10.1016","volume":"21","author":[{"given":"Susan P.","family":"Demarest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjodh S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP14339.RA_bb0005","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Phys."},{"key":"10.4158\/EP14339.RA_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jama.284.4.423b","article-title":"JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations","volume":"284","author":"Phillips","year":"2000","journal-title":"JAMA."},{"key":"10.4158\/EP14339.RA_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006605.pub2","article-title":"Long-term opioid management for chronic noncancer pain","author":"Noble","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"10.4158\/EP14339.RA_bb0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/AJP.0b013e3181d1059d","article-title":"Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment","volume":"26","author":"Rhodin","year":"2010","journal-title":"Clin J Pain."},{"key":"10.4158\/EP14339.RA_bb0025","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1001\/archinternmed.2010.391","article-title":"The comparative safety of analgesics in older adults with arthritis","volume":"170","author":"Solomon","year":"2010","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP14339.RA_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00044067-200507000-00003","article-title":"The endogenous opioid system and clinical pain management","volume":"16","author":"Holden","year":"2005","journal-title":"AACN Clin Issues."},{"key":"10.4158\/EP14339.RA_bb0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/er.2009-0009","article-title":"The effects of opioids and opioid analogs on animal and human endocrine systems","volume":"31","author":"Vuong","year":"2010","journal-title":"Endo Rev."},{"key":"10.4158\/EP14339.RA_bb0040","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.2174\/138161212803582414","article-title":"Non-analgesic effects of opioids: opioids and the endocrine system","volume":"18","author":"Elliott","year":"2012","journal-title":"Curr Pharm Des."},{"key":"10.4158\/EP14339.RA_bb0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000123558","article-title":"Differential effects of opioid peptides and alkaloids on anterior pituitary hormone secretion","volume":"37","author":"Delitala","year":"1983","journal-title":"Neuroendocrinology."},{"key":"10.4158\/EP14339.RA_bb0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1526-4637.2012.01368.x","article-title":"Testosterone replacement therapy outcomes among opioid users: The Testim Registry in the United States (TRiUS)","volume":"13","author":"Blick","year":"2012","journal-title":"Pain Med."},{"key":"10.4158\/EP14339.RA_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-8069-6-69","article-title":"Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats","volume":"6","author":"Aloisi","year":"2010","journal-title":"Mol Pain."},{"key":"10.4158\/EP14339.RA_bb0060","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1210\/jc.2006-0599","article-title":"Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility","volume":"91","author":"Agirregoitia","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14339.RA_bb0065","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","article-title":"Endocrine consequences of long-term intrathecal administration of opioids","volume":"85","author":"Abs","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14339.RA_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00002508-200009000-00011","article-title":"Hypogonadism in patients treated with intrathecal morphine","volume":"16","author":"Finch","year":"2000","journal-title":"Clin J Pain."},{"key":"10.4158\/EP14339.RA_bb0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1054\/jpai.2002.126790","article-title":"Hypogonadism in men consuming sustained-action oral opioids","volume":"3","author":"Daniell","year":"2002","journal-title":"J Pain."},{"key":"10.4158\/EP14339.RA_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.2010.03159.x","article-title":"Decreased bone density in men on methadone maintenance therapy","volume":"106","author":"Grey","year":"2011","journal-title":"Addiction."},{"key":"10.4158\/EP14339.RA_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1300\/J069v21n04_05","article-title":"Narcotic-induced hypogonadism during therapy for heroin addiction","volume":"21","author":"Daniell","year":"2002","journal-title":"J Addict Dis."},{"key":"10.4158\/EP14339.RA_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","article-title":"Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain","volume":"9","author":"Daniell","year":"2008","journal-title":"J Pain."},{"key":"10.4158\/EP14339.RA_bb0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00002508-200205000-00002","article-title":"Sex hormone suppression by intrathecal opioids: a prospective study","volume":"18","author":"Roberts","year":"2002","journal-title":"Clin J Pain."},{"key":"10.4158\/EP14339.RA_bb0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.suponc.2012.05.002","article-title":"Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain","volume":"10","author":"Davis","year":"2012","journal-title":"J Support Oncol."},{"key":"10.4158\/EP14339.RA_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jc.2004-0929","article-title":"Lichtermann, Klingmiiller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence","volume":"90","author":"Bliesener","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14339.RA_bb0110","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer."},{"key":"10.4158\/EP14339.RA_bb0115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14339.RA_bb0120","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14339.RA_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-9-26","article-title":"Hormone replacement therapy in morphine-induced hypogonad-ic male chronic pain patients","volume":"9","author":"Aloisi","year":"2011","journal-title":"Reprod Biol Endocrinol."},{"key":"10.4158\/EP14339.RA_bb0130","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-410X.2012.10968.x","article-title":"Clomiphene citrate is safe and effective for long-term management of hypogonadism","volume":"110","author":"Moskovic","year":"2012","journal-title":"BJU Int."},{"key":"10.4158\/EP14339.RA_bb0135","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1517\/13543780903405608","article-title":"Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency","volume":"18","author":"Kaminetsky","year":"2009","journal-title":"Expert Opin Investig Drugs."},{"key":"10.4158\/EP14339.RA_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1743-6109.2009.01454.x","article-title":"Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost","volume":"7","author":"Taylor","year":"2010","journal-title":"J Sex Med."},{"key":"10.4158\/EP14339.RA_bb0145","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1176\/ajp.137.7.862","article-title":"Suppression of plasma cortisol in depressed patients by acute intravenous methadone infusion","volume":"137","author":"Gold","year":"1980","journal-title":"Am J Psychiatry."},{"key":"10.4158\/EP14339.RA_bb0150","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(82)92830-6","article-title":"Methadone induced hypoadrenalism","volume":"2","author":"Dackis","year":"1982","journal-title":"Lancet."},{"key":"10.4158\/EP14339.RA_bb0155","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1210\/jcem-60-5-891","article-title":"Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects","volume":"60","author":"Rittmaster","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14339.RA_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jcem-65-2-295","article-title":"Inhibition of the adrenocorticotropin response to surgery in humans: Interaction between dexamethasone and fentanyl","volume":"65","author":"Raff","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14339.RA_bb0165","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jpain.2006.04.011","article-title":"DHEAS deficiency during consumption of sustained-action prescribed opioids: Evidence for opioid-induced inhibition of adrenal androgen production","volume":"7","author":"Daniell","year":"2006","journal-title":"J Pain."},{"key":"10.4158\/EP14339.RA_bb0170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2796.2005.01483.x","article-title":"Chronic fentanyl application induced adrenocortical insufficiency","volume":"257","author":"Oltmanns","year":"2005","journal-title":"J Intern Med."},{"key":"10.4158\/EP14339.RA_bb0175","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1055\/s-0029-1202851","article-title":"Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth considering","volume":"117","author":"Schimke","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.4158\/EP14339.RA_bb0180","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00228-011-0992-9","article-title":"Tramadol-induced adrenal insufficiency","volume":"67","author":"Debono","year":"2011","journal-title":"Eur J Clin Pharmacol."},{"key":"10.4158\/EP14339.RA_bb0185","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2265.2007.02779.x","article-title":"Secondary adrenal failure and secondary amenorrhea following hydromorphone treatment","volume":"66","author":"Mussig","year":"2007","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14339.RA_bb0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/sj.npp.1300856","article-title":"The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress","volume":"31","author":"Chong","year":"2006","journal-title":"Neuropsychopharmacology."},{"key":"10.4158\/EP14339.RA_bb0195","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.psyneuen.2009.05.013","article-title":"Endocrine consequences of opioid therapy","volume":"34S","author":"Aloisi","year":"2009","journal-title":"Psychoneuroendocrinology."},{"key":"10.4158\/EP14339.RA_bb0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2005-870230","article-title":"Effect of opiates on growth hormone secretion in acromegaly","volume":"37","author":"Bhansali","year":"2005","journal-title":"Horm Metab Res."},{"key":"10.4158\/EP14339.RA_bb0205","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/eje.0.1370631","article-title":"Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects","volume":"137","author":"Villa","year":"1997","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14339.RA_bb0210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-69-2-356","article-title":"Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone","volume":"69","author":"Delitala","year":"1989","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14339.RA_bb0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000124091","article-title":"Morphine-induced TSH release in normal and hypothyroid subjects","volume":"40","author":"Devilla","year":"1985","journal-title":"Neuroendocrinology."},{"key":"10.4158\/EP14339.RA_bb0220","first-page":"1249","article-title":"Effects of naloxone infusion on pulsatile thyrotropin secretion","volume":"78","author":"Samuels","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14339.RA_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/13556210500351263","article-title":"Enhanced prolactin levels in opium smokers","volume":"10","author":"Moshtaghi-Kashanian","year":"2005","journal-title":"Addict Biol."},{"key":"10.4158\/EP14339.RA_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000346110","article-title":"Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients","volume":"67","author":"Glahn","year":"2013","journal-title":"Neuropsychobiology."},{"key":"10.4158\/EP14339.RA_bb0235","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1592\/phco.22.13.1188.33526","article-title":"Fentanyl-associated syndrome of inappropriate antidiuretic hormone secretion","volume":"22","author":"Kokko","year":"2002","journal-title":"Pharmacotherapy."},{"key":"10.4158\/EP14339.RA_bb0240","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archinte.163.8.949","article-title":"Central nervous system active medications and risk for fractures in older women","volume":"163","author":"Ensrud","year":"2003","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP14339.RA_bb0245","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.amjmed.2005.07.033","article-title":"Bone mineral density in subjects using central nervous system-active medications","volume":"118","author":"Kinjo","year":"2005","journal-title":"Am J Med."},{"key":"10.4158\/EP14339.RA_bb0250","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bone.2011.11.014","article-title":"Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture","volume":"50","author":"Nelson","year":"2012","journal-title":"Bone."},{"key":"10.4158\/EP14339.RA_bb0255","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11606-009-1218-z","article-title":"Relationship of opioid use and dosage levels to fractures in older chronic pain patients","author":"Saunders","year":"2010","journal-title":"J Gen Intern Med."},{"key":"10.4158\/EP14339.RA_bb0260","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.2174\/138161212803582487","article-title":"Non-analgesic effects of opioids: the interaction of opioids with bone and joints","author":"Mattia","year":"2012","journal-title":"Curr Pharm Des."},{"key":"10.4158\/EP14339.RA_bb0265","article-title":"Effects of testosterone treatment on bone mineral density in hypogonadal men receiving intrathecal opioids","author":"Finch","year":"2014","journal-title":"Pain Practice"},{"key":"10.4158\/EP14339.RA_bb0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000054586","article-title":"Expression of opioid receptors in osteoblast-like MG-63 cells and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells","volume":"72","author":"Perez-Castrill\u00f3n","year":"2000","journal-title":"Neuroendocrinology."}],"updated-by":[{"DOI":"10.4158\/1934-2403-21.5.559","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000}}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20357670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20357670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/RN2J400R22765881.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T03:41:53Z","timestamp":1717645313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20357670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1530891X20357670"],"URL":"https:\/\/doi.org\/10.4158\/ep14339.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}